GENETICXCHANGE PARTNERS WITH ORACLE
TO PROVIDE
DATA INTEGRATION SOLUTION;
SUPPORTS ORACLE'S INFORMATION ARCHITECTURE FOR LIFE SCIENCES
MENLO PARK, CA - April 16, 2002 - geneticXchange, the premiere provider of data access and integration software solutions for the life sciences industry, today announced its support of Oracle's Information Architecture for Life Sciences, an e-business platform that integrates scientific and business applications for pharmaceutical and biotech companies. geneticXchange provides the ability to seamlessly access and integrate life science data from virtually any external or internal source, including flat files, websites, algorithms, relational databases, and proprietary formats, for high-throughput loading and analysis within an Oracle® environment.
"The biotech sector has undergone an 'industrialization' in the ability to generate new scientific data through innovative new equipment and techniques, but it has not seen the same step-change in the automation of workflows and tools for the scientists utilizing that data," explained Jeff Edwards, president and COO of geneticXchange. "We are leading the charge to change that by providing real-time access to remote data sources and automated workflows to make discovery research faster, cheaper, and more productive. We are very pleased to be working more closely with Oracle as part of its Information Architecture offering to help provide companies an integrated, end-to-end life sciences solution that covers a full spectrum of technologies, applications, and data resources."
"It's clear that data integration is an important part of the drug discovery process, and geneticXchange's approach, we believe, offers a compelling value proposition for biotech and pharmaceutical companies," said Jon Simmons, Vice President, Life Sciences at Oracle Corp. "Through a partnering approach with best-of-breed players like geneticXchange, we can uniquely offer our customers a platform of applications and technologies across the entire life sciences value chain."
geneticXchange's K1 System provides access to all life science data as if it were locally present. This enables scientists and researchers to discover important new relationships and potential drug targets by having a unified view of all pertinent data in one productive workflow. It also enables customers to easily add and maintain data sources in a flexible, scalable way, to respond quickly to the ever-changing requirements of the life sciences data environment.
Key capabilities of the geneticXchange solution include:
- Automated, Unified Access to 60+ leading scientific data sources and algorithms, as well as the tools to easily add new sources, such as data from mass spectrometers, assay data, LIMS systems, clinical data, chemo-informatic data, other discovery platforms, etc.
- Transformational Processor - uniquely handles complex nested data structures, which are common in life science data, without the need to flatten files. This offers significant time, performance, and productivity gains for both researchers and IT.
- Powerful Query Engine - enables real-time, ad-hoc queries across multiple data sources and automated discovery workflows, all using a standard SQL interface.
About geneticXchange
geneticXchange provides the onlysystem data integration platform to help accelerate the drug discovery process. geneticXchange's powerful K1 System software product provides rapid, real-time access to, and integration of, complex dispersed scientific data. The result is increased productivity, reduced risk and accelerated time-to-market for biotech and pharmaceutical companies. World leaders such as the Genome Institute of Singapore and Genomics Collaborative Inc. leverage the K1 System to help realize the promise of 'in-silico' drug discovery. geneticXchange is headquartered in Menlo Park, Calif., and can be reached at , info or www.geneticXchange.com.# # #
Oracle is a registered trademark of Oracle Corporation. All other trademarks are the property of their respective owners.
Contact Information:
geneticXchange, Inc.
Email: press
www.geneticxchange.com